Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472501 - 472520 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.5MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.5MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.5MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.5MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.75MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.75MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.75MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.75MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK52) niraparib and abiraterone | AKEEGA 500MG/100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01XK52) niraparib and abiraterone | AKEEGA 500MG/100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01XK52) niraparib and abiraterone | AKEEGA 500MG/50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01XK52) niraparib and abiraterone | AKEEGA 500MG/50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01XL02) talimogene laherparepvec | IMLYGIC /1MPFU/ML | 1M | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | AmgenUSA,Inc. |
| USA | (L01XL02) talimogene laherparepvec | IMLYGIC /1MPFU/ML | 1M | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | AmgenUSA,Inc. |
Pages
